Even in an era of remarkable therapeutics for neovascular age-related macular degeneration, there remains a lack of therapies ...

IDE approval by the FDA marks a significant milestone in the global expansion of the i-SIGHT2 study, which is already actively enrolling and treating study participants in the United Kingdom, ...

Dry age-related macular degeneration is the most common form of the disease, affecting millions of older Americans, according to the National Eye Institute. The condition develops ...

Learning to read again Study participant Sheila Irvine, a patient at Moorfields Eye Hospital, training with the PRIMA device. (Courtesy: Moorfields Eye Hospital) A tiny wireless implant inserted under ...

Doris is an 86-year-old woman who has been experiencing blurred vision in the left eye for the past month. B. Assessment and diagnosis only; I refer for treatment. C. Assessment only; I refer for ...

Scientists have developed the first ever retinal implant capable of restoring sight to people suffering from vision loss, according to a new study. The breakthrough, made by Neuralink competitor ...

There are two types of macular degeneration: dry and wet. Dry age-related macular degeneration is the most common type — it ...

Age-related macular degeneration (AMD) is a leading cause of blindness in the older population. Geographic atrophy is an advanced stage of dry AMD, characterized by irreversible vision loss due to the ...

Optimal dose intended for Phase 3 demonstrates statistically significant reduction in lesion growth (31%) versus control at 12 months (p< ...

Dry age-related macular degeneration is the most common type — it happens when small deposits form under the retina, causing ...

As people age, vision naturally declines, and the risk of eye conditions increases. That includes age-related macular degeneration (AMD), a condition that typically occurs in patients older than 50.